Is N-acetyl cysteine (NAC) effective in treating transaminitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

N-acetyl cysteine in Treatment of Transaminitis

N-acetyl cysteine (NAC) is strongly recommended for acetaminophen-induced transaminitis and acute liver failure, but should only be used in the context of clinical trials for non-acetaminophen-related transaminitis. 1

Effectiveness Based on Etiology

Acetaminophen-Induced Transaminitis

  • NAC is highly effective in preventing and treating acetaminophen-induced liver injury when administered early 1
  • The American Gastroenterological Association (AGA) provides a strong recommendation for NAC use in acetaminophen-associated acute liver failure (ALF), despite the very low quality of evidence 1
  • NAC improves mortality in acetaminophen-induced liver injury (relative risk 0.65,95% CI 0.43-0.99) 1
  • NAC should be initiated immediately without waiting for acetaminophen level results if acetaminophen overdose is suspected 1, 2

Non-Acetaminophen-Induced Transaminitis

  • For non-acetaminophen-related transaminitis, the AGA recommends NAC use only in the context of clinical trials 1
  • Post-hoc analysis of one study showed mortality benefit in patients with stage 1 or 2 hepatic encephalopathy, but not in overall non-acetaminophen ALF patients 1
  • Some evidence suggests NAC may be beneficial in post-transarterial chemoembolization transaminitis in hepatocellular carcinoma patients 3

Mechanism of Action

  • NAC works through multiple mechanisms to protect the liver: 4, 5
    • Replenishes glutathione stores depleted during acetaminophen metabolism 2
    • Acts as a direct free radical scavenger 5, 6
    • Serves as an alternate substrate for conjugation with toxic metabolites 2
    • Modulates inflammatory cytokines like TNF-alpha and IL1-beta 5
    • Has immunomodulatory effects that reduce oxidative stress 4, 5

Dosing and Administration

For Acetaminophen Overdose

  • Oral loading dose: 140 mg/kg followed by maintenance doses 2
  • Intravenous regimen: 150 mg/kg for 1 hour, then 12.5 mg/kg/h for 4 hours, followed by 6.25 mg/h for 67 hours 1, 3
  • Treatment should be initiated as soon as possible, ideally within 8-10 hours of ingestion 1, 7

For Transaminitis Management

  • For post-TACE transaminitis: IV NAC for 72 hours has shown significant reduction in AST and ALT levels 3
  • For patients with severe transaminase elevation, paracetamol should be avoided if possible 8
  • If paracetamol is necessary in patients with elevated transaminases, limit dose to 2g/day with daily monitoring 8

Timing and Efficacy

  • Treatment timing is critical for effectiveness: 1, 7
    • NAC initiated within 8 hours: 2.9% risk of severe hepatotoxicity 1, 9
    • NAC initiated within 10 hours: 6.1% risk of severe hepatotoxicity 1, 9
    • NAC initiated after 10 hours: 26.4% risk of severe hepatotoxicity 1, 9
  • NAC should be started as early as possible and within 24 hours of acetaminophen ingestion 2

Special Considerations and Pitfalls

  • NAC should be administered to patients with hepatic failure thought to be due to acetaminophen, even without confirmed levels 1, 9
  • In cases of ALF of indeterminate cause, NAC can be considered as some cases may be related to unrecognized acetaminophen toxicity 1
  • Patients may underreport their actual paracetamol intake, making clinical assessment challenging 8
  • Patients may present with elevated transaminases despite being stratified as "no risk" on the Rumack-Matthew nomogram due to inaccurate history or increased susceptibility 9

Adverse Effects

  • Oral administration may cause nausea, vomiting, and other gastrointestinal symptoms 2
  • IV administration may cause anaphylactic reactions and cutaneous adverse events 7
  • Rash with or without mild fever has been observed rarely 2
  • Overall, NAC has a favorable safety profile with relatively rare side effects 6

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.